Over 100 years of combined experience supporting your immunotoxicology studies
Burleson Research Technologies is a global contract research organization (CRO) that provides laboratory services to biotechnology, pharmaceutical, chemical manufacturing, government, and healthcare industries specializing in pre-clinical immunotoxicology studies.
Founded in 1996 by Drs. Gary and Florence Burleson, BRT started out with 2,000 sq. ft. of laboratory space and a vision to become a global provider of customized immunotoxicology services. While it began with just the two of them, over the years BRT has added staff, space, and services to expand its offerings and better serve its clients.
Today, BRT occupies a GLP compliant, AAALAC accredited facility with administrative, laboratory, and vivarium space. Our scientific staff offers more than 100 years of combined experience to support client studies around the globe.
Learn more about our services and capabilities here.